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Introduction 
According to the Centre for Evidence-Based Medicine’s hierarchies of evidence, systematic reviews 
of homogenous well-conducted randomised controlled trials (RCTs) provide the best evidence for 
evaluating intervention effectiveness [1]. Homogeneity implies that each study included in a meta-
analysis is estimating a single, true underlying relative intervention effect, so that any differences in 
estimates between studies are due to sampling error alone [2]. If homogeneity does not hold, a 
single, fixed treatment effect meta-analysis model should not be assumed and a random effects 
model may be more appropriate [2] [3]. In systematic reviews of interventions for mental health, it 
could be argued that the homogeneity assumption is unlikely to hold in general. This is because the 
clinical variation observed across patient populations, therapist fidelity, intervention and 
comparator conditions, and outcomes (both patient- and clinician-reported) can give rise to 
statistical heterogeneity in meta-analysis. Indeed, heterogeneity might be considered inevitable [4].  
In systematic reviews of mental health interventions, the presence of statistical heterogeneity may 
be attributable to the complexity of the intervention being evaluated leading to potentially 
important differences across studies. ‘Complexity’ itself is a contested term [5], however the MRC 
have described the characteristics of complex interventions as having: 
 A number of interacting components within the experimental and control interventions, 
 A number and difficulty of behaviours required by those delivering or receiving the 
intervention,  
 A number of groups or organisational levels targeted by the intervention 
 A number and variability of outcomes 
 A degree of flexibility or tailoring of the intervention permitted [6]. 
These characteristics may, or may not, be present in every complex intervention. Petticrew et al 
classify characteristics of complexity as (1) those, which relate to the intervention itself (such as 
multiple interacting components and flexibility of implementation) and (2) those which relate to the 
interventions’ causal pathway (such as interaction with context, multiple mediators and moderators 
of effect) [7].  
Strategies to handle complex interventions in meta-analysis range from “lumping” all interventions 
together [9] to sophisticated statistical modelling techniques [34]. The aim of this paper is to give an 
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overview of the different analytical strategies suggested for incorporating intervention complexity in 
a systematic review, illustrated using a subset of studies from a Cochrane review examining 
psychological therapies for reducing depressive symptoms post-coronary heart disease [8]. We 
consider complexity only as it relates to the intervention and conceptualise a complex intervention 
as one, which has multiple, potentially interacting components. This is the most common 
interpretation [9]. Interested readers are referred to a special edition of the Journal of Clinical 
Epidemiology for consideration of strategies for handling to handle other aspects of complexity in 
systematic reviews [10].  
 
Formulating the research question – lumping or splitting? 
The analytical strategy for synthesising complex interventions should be pre-specified and begins 
with the formulation of a sensible research question, which in turn depends on the purpose of the 
review [11] [12]. The specification of a review’s objectives shapes whether the analytical strategy 
will “lump” or “split” interventions. For example, ‘in principle’ research questions such as “do 
psychological therapies (as a whole), reduce depression after coronary heart disease?” might take a 
lumping approach to analysis, since this question seeks to understand effectiveness in general. 
However, when complex interventions are ‘lumped’ together to form a single comparator, any 
between interventions variation is masked and is likely to manifest as increased, but unexplained, 
heterogeneity. Of course, the decision to lump interventions may also be taken for practical reasons, 
such as when there are few eligible studies for inclusion in the review. 
Consider Figure 1, which is adapted from a Cochrane review of 36 psychological interventions for 
coronary heart disease [8]. The outcome of interest here is reduction in depressive symptoms, for 
which 11 studies were included. The comparison is any psychological intervention vs control, where 
control is defined as standard care/ treatment as usual (TAU). A fixed-effect meta-analysis was 
conducted by the authors and a standardised mean reduction of -0.18 (95% Confidence Interval [CI] -
0.24 to -0.12) suggests that psychological interventions may affect a modest reduction in depression 
post-coronary heart disease. However, the p-value for the chi-square statistic provides extremely 
strong evidence against the null hypothesis of homogeneity (i.e. that interventions are estimating a 
single underlying treatment effect).  
 
Figure 1 about here 
Figure 2 about here 
 
The I2 statistic suggests that 75% of the variation between studies is attributable to heterogeneity 
and not chance. To account appropriately for the observed between-study variation a random-effect 
meta-analysis may have been more appropriate [2]. However, this would still only answer an ‘in 
principle’ question of general effectiveness and results would not enable a clinician to select a 
specific psychological intervention for their patient. The meaningful analysis of complex 
interventions can therefore pose problems if a ‘lumped’ approach is followed. Further exploration 
can be achieved by conducting an a priori specified sub-group analysis [3]. Figure 2 shows subgroup 
analysis by mode of therapy delivery, however this does not appear to explain the observed 
heterogeneity (Individual therapy I2= 77%; Group therapy I2=86%), and the test for subgroup 
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differences is non-significant (p=0.31). In principle, the interventions could be further sub-grouped 
such as “individual + weekly meetings” or “group + weekly meetings + telephone support”. However, 
caution should be exercised since such analyses may suffer from low power due to the small number 
of included studies in each grouping. If the purpose of a review is to investigate which type of 
psychological intervention is effective, or which intervention characteristics are effective, then a 
review which categorises the intervention characteristics and ‘splits’ the analysis by intervention 
type may be the more appropriate and robust strategy. This can either be achieved as a series of 
separate reviews [13-16] or as separate analyses within the same review [17].  
 
Categorisation of intervention characteristics 
There are a number of ways in which a splitting approach can be applied for meta-analyses of 
complex interventions. One possibility is to use the theoretical underpinning of the interventions to 
construct “clinically meaningful units”, which should be specified a priori [18]. In clinical psychology 
this might include classification by intervention modality such as cognitive behavioural therapy, 
humanistic therapy, or behavioural therapy. In reviews of mental ill-health prevention, interventions 
could be grouped by psychological or behavioural theory, such as the theory of planned behaviour, 
health belief model, social-cognitive theory, and so on [19] [20]. In Figure 3 the psychological 
interventions for coronary heart disease have been categorised according to intervention modality. 
The information was obtained from the Characteristics of Studies tables included in the original 
Cochrane review. The three modalities were cognitive behavioural therapy (CBT), behavioural 
therapy (BT) and counselling based interventions. Of these, we note only behavioural therapy was 
associated with a reduction in depression and the I2 is 0%. However, the between study 
heterogeneity is still very high for CBT and counselling, and further investigation is warranted (note 
that estimates of heterogeneity become problematic when few studies are involved). One could 
disaggregate the intervention modalities further; for example, under CBT one might be interested in 
problem solving therapies or rational-emotive behavioural therapies [21]. Note however that a 
balance needs to be found between a sufficiently detailed categorisation that can explain 
heterogeneity and sufficient numbers of studies for statistical power and to avoid spurious findings. 
 
Figure 3 about here 
 
Components-based network meta-analysis 
The obvious difficulty for standard, pairwise meta-analyses which seek to disaggregate complex 
interventions is that there are typically too few studies to allow clinically useful ‘splitting’ and 
inevitably, some degree of aggregation is needed for a meta-analysis to be conducted. In network 
meta-analyses, however, the potential for disaggregating the intervention is more promising [18]. A 
network meta-analysis (NMA) is an extension of traditional pair-wise meta-analysis to include 
multiple interventions, as long as these interventions form a connected network of evidence (see 
Figure 4, which shows a “star network” where all interventions have been compared with the same 
common comparator - TAU). A key advantage of NMA is that it produces summary estimates of 
relative effectiveness regardless of whether interventions have been compared directly and ranks 
them according to the outcome measured (e.g., effectiveness or safety). An additional advantage of 
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NMA is that it allows more studies to be combined, as long as they connect to the network (eg CBT 
vs Counselling studies could be added to Figure 4), bringing increased precision in the estimated 
intervention effects and the potential to explore statistical heterogeneity. For further details on the 
statistical methodology readers should see [22-24] and for a discussion of the implications for 
systematic review methodology see [25]. 
Figure 4 about here 
The ‘clinically meaningful unit’ classification approach explored above has been applied to a network 
of psychotherapies for treating depression [26], treating acute depression in primary care [27] and 
psychotherapies for panic disorder [28]. Indeed, the ‘clinically meaningful unit’ analysis presented 
above in Figure 3 could be re-analysed as an NMA with three interventions, and sharing a common 
heterogeneity parameter. Figure 4 depicts the network structure for this analysis; note that all active 
psychological interventions are compared to the ‘usual care’ node forming a star-shaped network. 
Just as in the pairwise meta-analyses above, it is assumed that the standard/ TAU comparators are 
similar enough to be combined with the additional assumption that this must now apply across all 
interventions [22]. 
In Figure 5 the findings from the NMA are reported not only for the comparisons on which there is 
direct evidence but also for those where it is absent e.g BT vs CBT. There is substantial uncertainty 
surrounding the pairwise estimates of intervention effect, and the only comparison that reaches 
conventional statistical significance is BT vs TAU (note the NMA was performed in a Bayesian 
framework, which accounts for the wider confidence intervals when compared to Fig. 3). On the 
basis of this NMA, CBT is ranked 3rd (95% CIs 1st to 4th) best in terms of reducing depressive 
symptoms, BT is ranked 1st (95% CIs 1st to 3rd), and counselling is ranked 2nd (95% CIs 1st to 4th). 
Treatment as usual is the ‘worst’ intervention.  Note the confidence intervals around the rankings 
reflect the considerable uncertainty observed in the effect estimates. In NMA a single between study 
heterogeneity parameter is typically assumed [22]. Here the estimate of Tau2 is 0.11 which might be 
considered to represent a moderate level of heterogeneity. Note that the NMA assumes that the 
heterogeneity is the same regardless of which comparison is being made. This may not be 
appropriate here, since we found more heterogeneity in the CBT vs TAU comparison than for the 
other comparisons (Fig. 3). This suggests that the CBT classification may be too broad to capture the 
complex nature of CBT interventions. 
 
Figure 5 about here 
 
Multi-components-based network meta-analysis 
Within a NMA framework, the analyst has greater flexibility to evaluate complex multi-component 
interventions and to investigate whether interventions with a particular component(s) are more 
likely to be effective. Components are defined as the “active ingredients”, ‘intervention techniques’, 
or ‘elements of an intervention that have the potential to causally influence outcomes’ [9]. As such 
they may be classified on practical elements e.g. activities, mode of delivery, setting and/ or on 
theoretical underpinnings of the intervention. If there are common components across all 
interventions in the network, the components effectively become the intervention ‘nodes’ in the 
network and a NMA can be conducted. Figure 6 represents a multi-components-based network plot 
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for the coronary heart disease example. Welton et al [29] conducted a components-based NMA for 
the coronary heart disease network. Interventions were classified according to five key components; 
educational, behavioural, cognitive, relaxation, and psychosocial support. Describing their model as 
a meta-regression based extension to NMA, three models were evaluated in a Bayesian framework: 
(1) an additive main effects model which assumes that the effect of each component adds (i.e. no 
synergistic or antagonistic effects), (2) a 2-way interaction model (allowing pairs of components to 
have either a bigger or smaller effect than would be expected from the sum of their effects alone) 
and (3) a full interaction model for interventions described as having >2 components (e.g. 
cognitive+behavioral+support). To illustrate, their results for the depression outcome are shown in 
Figure 7 for the main effects additive model. This analysis answers the question ‘‘which intervention 
component has the greatest probability of being most effective?’’ Compared to the broader 
categorisation used in Fig. 5, having broken down interventions into their component parts 
heterogeneity is now reduced; Tau2 = 0.03. There is some evidence that an intervention with a 
cognitive and/or behavioural component(s) was associated with a reduction in standardized mean 
depression score; for the cognitive component the pooled SMD was -0.26 (95% credible interval: -
0.55 to 0.02) and for behavioural it was SMD -0.24 (95% credible interval: -0.42 to -0.06).  
 
 
Figure 6 about here 
Figure 7 about here 
 
 
Discussion 
Component-based network meta-analysis is an option for the synthesis of complex interventions in 
the presence of heterogeneity. Of course, intervention categorisation is only one dimension 
contributing to heterogeneity in meta-analyses of complex interventions. In the above example, 
heterogeneity was explained by intervention definition but this may not be the case for all examples, 
where additional factors may cause residual heterogeneity (for example an imbalance of effect 
modifiers across studies). A possible source of confounding here is the control intervention. In RCTS 
in clinical psychology and psychiatry control interventions may take several forms – waiting list 
controls are common as are no intervention controls [30]. A psychological placebo, where the 
intervention is regarded as inactive by the researchers but is judged as active by the participants, 
may be used. Similarly an attention placebo could be used where the control mimics the 
theoretically inactive elements of an intervention, but not the active elements [31, 32]. Reviewers of 
complex interventions should also be mindful that treatment as usual and standard care may differ 
across settings, contexts and countries, even though systematic reviews have traditionally lumped 
these into a single control [33, 34].  Unfortunately, due to the small number of studies in the 
psychotherapy for coronary heart disease meta-analysis, further disaggregating by control 
intervention is of questionable value. 
Component based systematic reviews are becoming increasingly common as analysts realise the 
importance of identifying and investigating heterogeneity, regardless of its inevitability [35, 36]. 
However, one difficulty in a components based approach is the identification of distinct components 
from the published literature [37]. Complex interventions may not be described in sufficient detail to 
allow dismantling of key ingredients. Recent reporting guideline initiatives, such as CReDICI 2 
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(Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: 
revised guideline) [38] and CONSORT-SPI (Social and Psychological Interventions) [39] seek to 
address this. The MRCs recent guidance on process evaluations may also help identification of 
components, and assessment of delivery and fidelity of complex interventions [40]. How to classify 
complex interventions and disaggregate the multiple interacting components within them is an area 
of ongoing interest. Several taxonomies have been developed; some designed for use in specific 
clinical areas and others are generic [41]. Further research is needed to assess the application of 
taxonomies across clinical areas. Logic models describing the mechanisms of action and casual 
pathways of interventions are increasingly used to structure systematic reviews of complex 
interventions [42] and could also be used to inform the classification of intervention components. 
What is clear, however, is that whichever approach the analyst chooses to categorise interventions it 
is desirable that components be specified a priori, and published in a protocol before data extraction 
to avoid data-driven decisions and reduce the likelihood of spurious findings. 
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